Your browser doesn't support javascript.
loading
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala, Katharigatta N; Chandrashekharappa, Sandeep; Deb, Pran Kishore; Tratrat, Christophe; Pillay, Melendhran; Chopra, Deepak; Al-Shar'i, Nizar A; Hourani, Wafa; Dahabiyeh, Lina A; Borah, Pobitra; Nagdeve, Rahul D; Nayak, Susanta K; Padmashali, Basavaraj; Morsy, Mohamed A; Aldhubiab, Bandar E; Attimarad, Mahesh; Nair, Anroop B; Sreeharsha, Nagaraja; Haroun, Michelyne; Shashikanth, Sheena; Mohanlall, Viresh; Mailavaram, Raghuprasad.
Afiliação
  • Venugopala KN; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Chandrashekharappa S; Department of Biotechnology and Food Technology, Durban University of Technology, Durban, South Africa.
  • Deb PK; Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India.
  • Tratrat C; Faculty of Pharmacy, Department of Pharmaceutical Sciences, Philadelphia University, Amman, Jordan.
  • Pillay M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Chopra D; Department of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
  • Al-Shar'i NA; Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal, India.
  • Hourani W; Faculty of Pharmacy, Department of Medicinal Chemistry and Pharmacognosy, Jordan University of Science and Technology, Irbid, Jordan.
  • Dahabiyeh LA; Faculty of Pharmacy, Department of Pharmaceutical Sciences, Philadelphia University, Amman, Jordan.
  • Borah P; Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan.
  • Nagdeve RD; Pratiksha Institute of Pharmaceutical Sciences, Guwahati, India.
  • Nayak SK; Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur, India.
  • Padmashali B; Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur, India.
  • Morsy MA; Department of Chemistry, School of Basic Science, Rani Channamma University, Belagavi, India.
  • Aldhubiab BE; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Attimarad M; Faculty of Medicine, Department of Pharmacology, Minia University, El-Minia, Egypt.
  • Nair AB; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Sreeharsha N; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Haroun M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Shashikanth S; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
  • Mohanlall V; Department of Pharmaceutics, Vidya Siri College of Pharmacy, Bangalore, India.
  • Mailavaram R; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
J Enzyme Inhib Med Chem ; 36(1): 1472-1487, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34210233
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Bactérias / Indolizinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxirredutases / Proteínas de Bactérias / Indolizinas / Mycobacterium tuberculosis / Antituberculosos Idioma: En Ano de publicação: 2021 Tipo de documento: Article